DHR Add to watchlist
$198.14 0.47 (-0.24%)
After Hours: $198.14 +0.00 (+0.00%)
Last updated: Apr 15, 2026 23:09
52-Week Range
$198.14
$180.03 $198.14 $242.80

Fundamentals Overview

Danaher Corporation is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 39 P/B 2.67 P/S 5.7

Intrinsic value (DCF)

+2.3% upside vs price

Profitability

Net margin 14.7%

Risk (Beta)

0.99 — in line vol

Earnings & growth

EPS $5.08 Rev +13% Profit +31.8% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 52% confidence Risk: Moderate Volatility — Beta 0.99. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · Sentiment improving (2 upgrades)

Pressures (Sell):

3M vs S&P 500: -17.8% · 3M vs Healthcare sector: -11%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$140.11B
P/E (TTM)
38.98
EPS (TTM)
$5.08
Dividend Yield
0.36%
52-Week Range
$180.03 - $242.80
Volume vs Avg
N/A
Beta
0.99

About

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess...
Sector: Healthcare
Headquarters: US
Employees: 61,000
IPO Date: Dec 1978
Beta: 0.99 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 11, Equal Weight: 3, Neutral: 1, Outperform: 8, Overweight: 6, Sector Outperform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $202.61; current price is $198.14. That’s a +2.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 38.98
DCF value (model) $202.61 (2.3% upside)
PEG (TTM) N/A
P/B (TTM) 2.67
P/S (TTM) 5.7
P/FCF (TTM) 26.64
Liquidity & enterprise
Current Ratio (TTM) 1.87
Quick Ratio (TTM) 1.51
Cash Ratio (TTM) 0.68
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 14.71%
Gross margin (TTM) 60.93%
Operating margin (TTM) 20.91%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for DHR.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 11Equal Weight 3Neutral 1Outperform 8Overweight 6Sector Outperform 1
2 upgrades, 1 downgrade
Price Target Consensus
Current $198.14
Median $259.50
Consensus $255.00
Low consensus $230.00
High consensus $270.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain Outperform Outperform 2026-04-06
Jefferies maintain Buy Buy 2026-01-29
JP Morgan maintain Overweight Overweight 2026-01-29
TD Cowen maintain Buy Buy 2026-01-07
Guggenheim maintain Buy Buy 2026-01-05
Wells Fargo maintain Equal Weight Equal Weight 2025-12-15
Wells Fargo maintain Equal Weight Equal Weight 2025-10-23
TD Cowen maintain Buy Buy 2025-10-22
Barclays maintain Overweight Overweight 2025-10-22
Rothschild & Co downgrade Buy Neutral 2025-10-08
Evercore ISI Group maintain Outperform Outperform 2025-10-07
B of A Securities maintain Buy Buy 2025-09-22
Wells Fargo maintain Equal Weight Equal Weight 2025-07-23
Guggenheim maintain Buy Buy 2025-07-23
UBS maintain Buy Buy 2025-07-23
Baird maintain Outperform Outperform 2025-07-23
Baird maintain Outperform Outperform 2025-07-18
Scotiabank upgrade Sector Perform Sector Outperform 2025-07-11
Evercore ISI Group maintain Outperform Outperform 2025-07-08
Barclays maintain Overweight Overweight 2025-06-24
Guggenheim maintain Buy Buy 2025-04-23
Goldman Sachs maintain Buy Buy 2025-04-23
Baird maintain Outperform Outperform 2025-04-23
UBS maintain Buy Buy 2025-04-23
RBC Capital maintain Outperform Outperform 2025-04-23
Jefferies maintain Buy Buy 2025-04-22
Barclays maintain Overweight Overweight 2025-04-22
JP Morgan maintain Overweight Overweight 2025-04-22
Baird maintain Outperform Outperform 2025-04-16
Barclays upgrade Equal Weight Overweight 2025-04-10